Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Do the data support the comorbidity hypothesis for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial results?

Bach PB, Vickers AJ.

J Clin Oncol. 2011 May 1;29(13):e387; author reply e388-9. doi: 10.1200/JCO.2011.34.9027. Epub 2011 Mar 21. No abstract available.

PMID:
21422419
[PubMed - indexed for MEDLINE]
2.

Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.

Schröder FH, Roobol MJ.

BJU Int. 2009 Jan;103(2):143-4. doi: 10.1111/j.1464-410X.2008.08257.x. Epub 2008 Dec 5. No abstract available.

PMID:
19076150
[PubMed - indexed for MEDLINE]
3.

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK; PLCO Project Team.

J Natl Cancer Inst. 2005 Mar 16;97(6):433-8.

PMID:
15770007
[PubMed - indexed for MEDLINE]
Free Article
4.

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S.

PMID:
11189684
[PubMed - indexed for MEDLINE]
5.

Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Hasson MA, Fagerstrom RM, Kahane DC, Walsh JH, Myers MH, Caughman C, Wenzel B, Haralson JC, Flickinger LM, Turner LM; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):329S-348S.

PMID:
11189686
[PubMed - indexed for MEDLINE]
6.

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):251S-272S.

PMID:
11189683
[PubMed - indexed for MEDLINE]
7.

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Pinsky PF, Blacka A, Kramer BS, Miller A, Prorok PC, Berg C.

Clin Trials. 2010 Aug;7(4):303-11. doi: 10.1177/1740774510374091. Epub 2010 Jun 22.

PMID:
20571134
[PubMed - indexed for MEDLINE]
8.

Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.

Gohagan JK, Prorok PC, Kramer BS, Cornett JE.

J Urol. 1994 Nov;152(5 Pt 2):1905-9.

PMID:
7523735
[PubMed - indexed for MEDLINE]
9.

Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

O'Brien B, Nichaman L, Browne JE, Levin DL, Prorok PC, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):310S-328S.

PMID:
11189685
[PubMed - indexed for MEDLINE]
10.

Screening for prostate cancer: have we resolved the controversy?

Zhu X, Roobol MJ, Schröder FH.

Curr Opin Support Palliat Care. 2010 Sep;4(3):121-6. doi: 10.1097/SPC.0b013e32833abc21. Review.

PMID:
20489646
[PubMed - indexed for MEDLINE]
11.

Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.

Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, Caporaso N, Ziegler RG, Johnson CC, Weissfeld JL, Hoover RN, Hartge P, Palace C, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):349S-355S.

PMID:
11189687
[PubMed - indexed for MEDLINE]
12.

Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Stallings FL, Ford ME, Simpson NK, Fouad M, Jernigan JC, Trauth JM, Miller DS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):379S-389S.

PMID:
11189689
[PubMed - indexed for MEDLINE]
13.

The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.

Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK; PLCO Steering Committee.

Urol Oncol. 2004 Jul-Aug;22(4):358-61.

PMID:
15283897
[PubMed - indexed for MEDLINE]
14.

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.

Grubb RL 3rd, Pinsky PF, Greenlee RT, Izmirlian G, Miller AB, Hickey TP, Riley TL, Mabie JE, Levin DL, Chia D, Kramer BS, Reding DJ, Church TR, Yokochi LA, Kvale PA, Weissfeld JL, Urban DA, Buys SS, Gelmann EP, Ragard LR, Crawford ED, Prorok PC, Gohagan JK, Berg CD, Andriole GL.

BJU Int. 2008 Dec;102(11):1524-30. doi: 10.1111/j.1464-410X.2008.08214.x.

PMID:
19035857
[PubMed - indexed for MEDLINE]
15.

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Miller AB, Yurgalevitch S, Weissfeld JL; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):400S-406S.

PMID:
11189691
[PubMed - indexed for MEDLINE]
16.

Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.

Simpson NK, Johnson CC, Ogden SL, Gamito E, Trocky N, McGuire C, Martin J, Barrow S, Lamerato L, Flickinger LM, Broski KG, Engelhard D, Hilke C, Bonk J, Gahagan B, Gren LH, Childs J, Lappe K, Fouad M, Thompson J, Sullivan D; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):356S-378S.

PMID:
11189688
[PubMed - indexed for MEDLINE]
17.

[Impact of PSA screening on mortality. PLCO project team (prostate, lung, colorectal, ovarian cancer screening trial)].

Heidenreich A, Nitschmann S.

Internist (Berl). 2010 Feb;51(2):219-20. doi: 10.1007/s00108-009-2571-z. German. No abstract available.

PMID:
20107755
[PubMed - indexed for MEDLINE]
18.

Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Weissfeld JL, Fagerstrom RM, O'Brien B; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):390S-399S.

PMID:
11189690
[PubMed - indexed for MEDLINE]
19.

Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.

Lamerato LE, Marcus PM, Jacobsen G, Johnson CC.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):827-33. doi: 10.1158/1055-9965.EPI-06-0528.

PMID:
18398023
[PubMed - indexed for MEDLINE]
Free Article
20.

Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Pinsky PF, Ford M, Gamito E, Higgins D, Jenkins V, Lamerato L, Tenorio S, Marcus PM, Gohagan JK.

J Natl Med Assoc. 2008 Mar;100(3):291-8.

PMID:
18390022
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk